With its 4
th
Annual Global Customer Summit kicking off this morning in Philadelphia,
Veeva Systems announced dramatic growth of cloud-based Veeva CRM throughout the
continent. Since Veeva's official expansion into Europe
in April 2010, the company has delivered the advantages of cloud computing to
more than 35 life sciences companies across 20+ different European markets.
When all current deployments are complete, there will be over 30,000 European
pharmaceutical representatives using Veeva CRM to better manage their
relationships with customers. To support its large user base, Veeva has opened
major offices in Barcelona, Budapest
and Paris and, along with a network of
strategic partners, currently has more than 200 certified Veeva Administrators
to implement and support the cloud-based CRM solution in Europe.
Veeva's European
customers include dozens of emerging biotechs and specialty companies as well
as ten of the Top 20 global pharmaceutical companies. Key global customers
include Astellas Pharma, Boehringer Ingelheim, Daiichi Sankyo, Eli Lilly, and
Novartis; key specialty leaders include Actelion, Grünenthal, LEO Pharma, and
Stallergenes; and small and medium-sized customers include Human Genome
Sciences, Iroko Cardio, Mundipharma, and Pharco Pharma.
"Winning in today's
challenging European pharmaceutical environment requires a fundamentally
different commercial approach. To support our new commercial model, we wanted a
CRM solution that was truly pan-European, future-proof and agile enough to grow
with our organizational needs. Veeva CRM was the only solution to meet all
these business requirements," said Wim Kockelkoren, senior vice president EMEA
Commercial Effectiveness and CEE Region, Astellas Pharma Europe.
Actelion's Head of Global Commercial Excellence, Christoph Schmidt, PhD
added, "Our search for a single, global CRM solution was driven by today's
increasingly challenging business environment. In order to compete, we need the
tools that will enable us to gain a better understanding of our customer's
needs and be more responsive. Veeva offered industry-specific functionality for
all different user groups - from key opinion leader managers to key account
execs and field reps - around the world, all integrated within a single
solution."
Product Enhancements for Region-to-Region Support
Veeva's success in Europe
and elsewhere around the world is due in part to an industry-specific product
that is designed to easily meet regional and local needs. Most notably in Europe,
Veeva has integrated unique order management and data connector tools into the
product. Veeva CRM now includes online and offline order management
capabilities such as pricing optimization engines and other point-of-sale tools
to enable European sales reps to place orders directly from pharmacists during
the call even without an internet connection. Also, Veeva CRM's pre-built HCP
data connector tool accelerates customers' ability to integrate with any of the
top physician data providers. Thanks to multitenant cloud technology, Veeva CRM's
data connector makes it easy to add new or switch data sources using just
straightforward point-and-click design.
Veeva iRep Bolsters Global iPad Growth
Available in 20+
languages, Veeva iRep is the first system to combine CRM with comprehensive
Closed Loop Marketing (CLM) on the iPad. Veeva iRep has become the industry's
choice on the iPad with the largest installed base both in Europe
and worldwide, according to recent numbers.
"We recognised
iRep's closed-loop marketing functions and the iPad device's beautiful
presentation of multi-media content would support more interactive customer
engagements. With iRep, we expect that our account specialists will be more
connected, responsive and effective," said Dr. Simon Clough, managing director for
Daiichi Sankyo UK. "We're all about innovation that leads to
enhanced quality and value for our customers. We've adopted an aggressive
agenda for advancing everything from our science to our interactions with
stakeholders, and Veeva CRM supports it perfectly," he added.
According to Kevin Crowe, associate director
of marketing and sales operations at Human Genome Sciences Europe, "There is no
other solution like iRep for Pharma. Having our CRM and CLM capabilities
integrated on the iPad is extremely powerful. It will remodel how our
commercial teams operate by providing them with accurate, rich, timely customer
information on the go, and on a display that appeals to physicians."
Veeva's dramatic growth in Europe
accompanies a record-breaking year for the company on a global scale - Veeva
grew customers, deployed users, and employees each by over 100% in 2011. Eric
Newmark, program director with IDC Health Insights, which recently published
its "Vendor Assessment: 2011
Top 10 Life Science Software Vendors" report concludes, "Veeva is currently the
fastest-growing vendor in the sales and marketing space."
For more information, visit
www.veevasystems.com.
About Veeva Systems
Veeva Systems is the leader in cloud-based business solutions for the
global life sciences industry. Committed to innovation, product excellence and
customer success, Veeva has over 150 customers, ranging from the world's
largest pharmaceutical companies to emerging biotechs. Founded in 2007, Veeva
is a privately held company headquartered in the San Francisco Bay Area, with
offices in Philadelphia, Barcelona,
Budapest, Paris,
Beijing, Shanghai
and Tokyo.